Yifei Du

1.4k total citations
59 papers, 994 citations indexed

About

Yifei Du is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Yifei Du has authored 59 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Genetics and 11 papers in Genetics. Recurrent topics in Yifei Du's work include Mesenchymal stem cell research (14 papers), Cleft Lip and Palate Research (8 papers) and Bone Metabolism and Diseases (7 papers). Yifei Du is often cited by papers focused on Mesenchymal stem cell research (14 papers), Cleft Lip and Palate Research (8 papers) and Bone Metabolism and Diseases (7 papers). Yifei Du collaborates with scholars based in China, United States and Bangladesh. Yifei Du's co-authors include Hongbing Jiang, Jie Cheng, Hua Yuan, Yu Fu, Ning Chen, Rongyao Xu, Yongchu Pan, Yuli Wang, Chunbo Tang and Mingyue Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Environmental Pollution.

In The Last Decade

Yifei Du

54 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifei Du China 19 464 234 212 136 130 59 994
Ximeng Liu United States 11 593 1.3× 136 0.6× 307 1.4× 201 1.5× 130 1.0× 21 1.1k
Huabing Qi China 15 742 1.6× 330 1.4× 110 0.5× 156 1.1× 59 0.5× 23 1.2k
Youlin Deng China 7 551 1.2× 97 0.4× 123 0.6× 90 0.7× 95 0.7× 12 940
Marina D’Angelo United States 16 492 1.1× 202 0.9× 158 0.7× 135 1.0× 93 0.7× 20 1.1k
Katiúcia Batista Silva Paiva Brazil 15 405 0.9× 161 0.7× 210 1.0× 137 1.0× 61 0.5× 34 887
Stephen P. Henry United States 10 572 1.2× 178 0.8× 187 0.9× 119 0.9× 71 0.5× 12 1.1k
Yinshi Ren United States 22 560 1.2× 114 0.5× 117 0.6× 161 1.2× 86 0.7× 40 1.1k
Masaru Kaku Japan 20 425 0.9× 215 0.9× 70 0.3× 71 0.5× 92 0.7× 49 952
Marco Angelozzi United States 16 397 0.9× 102 0.4× 194 0.9× 63 0.5× 107 0.8× 26 879
Shousaku Itoh Japan 13 580 1.3× 112 0.5× 123 0.6× 428 3.1× 78 0.6× 28 1.1k

Countries citing papers authored by Yifei Du

Since Specialization
Citations

This map shows the geographic impact of Yifei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifei Du more than expected).

Fields of papers citing papers by Yifei Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifei Du. The network helps show where Yifei Du may publish in the future.

Co-authorship network of co-authors of Yifei Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yifei Du. A scholar is included among the top collaborators of Yifei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifei Du. Yifei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yunhe, Ziyue Wang, Yifei Du, et al.. (2025). Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities. Bioorganic & Medicinal Chemistry. 121. 118109–118109. 4 indexed citations
2.
Wu, Ji, Ziyue Wang, Bingbing Chen, et al.. (2025). ALK-based dual inhibitors: Focus on recent development for non-small cell lung cancer therapy. European Journal of Medicinal Chemistry. 291. 117646–117646. 4 indexed citations
3.
Chen, Yongqian, Yifei Du, Jialin Liu, et al.. (2025). Laser Cladding for Diamond-Reinforced Composites with Low-Melting-Point Transition Layer. Materials. 18(10). 2402–2402.
4.
Mao, Zhenxing, et al.. (2025). Risk Factors for Surgical Site Infection in Patients with Oral Cancer: A Systematic Review. Annals of Surgical Oncology. 32(13). 9942–9951.
5.
Zhao, Dan, Jian Song, Bingbing Chen, et al.. (2025). Discovery of novel coumarin-sulfonates as tubulin polymerization inhibitors targeting the colchicine-binding site with potent anticancer activities. Bioorganic & Medicinal Chemistry Letters. 125-126. 130284–130284. 1 indexed citations
6.
Qin, Ran, Jun Cao, Jianfeng Li, et al.. (2025). Targeting iron overload and macrophage polarization to treat diabetic periodontitis: Mechanisms and therapeutic strategies. Life Sciences. 377. 123805–123805. 1 indexed citations
7.
Ren, Jingnan, et al.. (2025). Effects of compound probiotics on growth performance, immunity, antioxidant capacity and gut microbiota in weaned rabbits. Frontiers in Veterinary Science. 12. 1714335–1714335.
8.
Liu, Wen‐Bo, Weiguang Yang, Bingbing Chen, et al.. (2025). Discovery of novel thienopyridine indole derivatives as inhibitors of tubulin polymerization targeting the colchicine-binding site with potent anticancer activities. European Journal of Medicinal Chemistry. 286. 117314–117314. 7 indexed citations
10.
Han, Yanxing, Yifei Du, Yixuan Zhang, et al.. (2024). Bioactive materials from berberine-treated human bone marrow mesenchymal stem cells promote alveolar bone regeneration by regulating macrophage polarization. Science China Life Sciences. 67(5). 1010–1026. 9 indexed citations
11.
Zhang, Yunlong, Yifei Du, Min Wang, et al.. (2023). Identification of genes associated with spontaneous regression of neuroblastoma. SHILAP Revista de lepidopterología. 1(1). e10–e10. 1 indexed citations
13.
Zheng, Yang, An Song, Yan Zhou, et al.. (2020). Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma. Journal of Cell Communication and Signaling. 14(4). 389–402. 26 indexed citations
14.
Zheng, Yang, Chundi Wang, Xu Ding, et al.. (2018). MiR-876-5p modulates head and neck squamous cell carcinoma metastasis and invasion by targeting vimentin. Cancer Cell International. 18(1). 121–121. 28 indexed citations
15.
Du, Yifei, Jin Bai, Xiaomeng Song, et al.. (2017). RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma. Oncology Reports. 38(4). 2378–2386. 11 indexed citations
16.
Wang, Yuli, Junchi Ma, Yifei Du, Jing Miao, & Ning Chen. (2016). Human Amnion-Derived Mesenchymal Stem Cells Protect Human Bone Marrow Mesenchymal Stem Cells against Oxidative Stress-Mediated Dysfunction via ERK1/2 MAPK Signaling. Molecules and Cells. 39(3). 186–194. 22 indexed citations
17.
Han, Yue, Yongchu Pan, Yifei Du, et al.. (2011). Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Nonsyndromic Orofacial Clefts Susceptibility in a Southern Chinese Population. DNA and Cell Biology. 30(12). 1063–1068. 29 indexed citations
18.
Tang, Chunbo, Ning Chen, Mingyue Wu, Hua Yuan, & Yifei Du. (2009). Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Research and Treatment. 117(2). 391–399. 78 indexed citations
20.
Lin, Jiangkai, et al.. (2006). Photodynamic therapy increases brain edema and intracranial pressure in a rabbit brain tumor model. Acta neurochirurgica. Supplementum. 96. 422–425. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026